Why it was recalled
cGMP Deviations
Product description
Atorvastatin 20 mg tablets, packaged in a) 30-count bottles (NDC 70518-1977-00) and b)90-count bottles (NDC 70518-1977-01), Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701.
Lot numbers, UPCs & expiration codes
Lot #: a) J0659819-110922, Exp. Date 11/30/2023; J0649932-093022, J0649917-093022 Exp. Date 10/31/2023, B2010060-121222, Exp. Date 03/31/24 Lot #: b) B1708575-060122, Exp. Date 05/31/2023; B1879236-092922, Exp. Date 12/31/2023
Where it was sold
RemedyRepack distributed product to consignees nationwide within the United States
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-0498-2023
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- Mar 20, 2023
- FDA report date
- Apr 12, 2023
- Quantity
- 3,426 bottles
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- RemedyRepack Inc.
Original FDA data
Every field from FDA enforcement report D-0498-2023, exactly as published.
Show all FDA fields
- City
- Indiana
- State
- PA
- Status
- Terminated
- Country
- United States
- Event ID
- 91980
- Address
- 625 Kolter Dr Ste 4
- Code information
- Lot #: a) J0659819-110922, Exp. Date 11/30/2023; J0649932-093022, J0649917-093022 Exp. Date 10/31/2023, B2010060-121222, Exp. Date 03/31/24 Lot #: b) B1708575-060122, Exp. Date 05/31/2023; B1879236-092922, Exp. Date 12/31/2023
- Postal code
- 15701-3571
- Report date
- Apr 12, 2023
- Product type
- Drugs
- Recall number
- D-0498-2023
- Classification
- Class II
- Recalling firm
- RemedyRepack Inc.
- Product quantity
- 3,426 bottles
- Termination date
- Oct 19, 2023
- Reason for recall
- cGMP Deviations
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- Atorvastatin 20 mg tablets, packaged in a) 30-count bottles (NDC 70518-1977-00) and b)90-count bottles (NDC 70518-1977-01), Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701.
- Distribution pattern
- RemedyRepack distributed product to consignees nationwide within the United States
- Recall initiation date
- Mar 20, 2023
- Initial firm notification
- Letter
- Center classification date
- Mar 31, 2023